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Abstract
Background: Recent research examining cross-platform correlation of gene expression
intensities has yielded mixed results. In this study, we demonstrate use of a correction factor for
estimating cross-platform correlations.
Results: In this paper, three technical replicate microarrays were hybridized to each of three
platforms. The three platforms were then analyzed to assess both intra- and cross-platform
reproducibility. We present various methods for examining intra-platform reproducibility. We also
examine cross-platform reproducibility using Pearson's correlation. Additionally, we previously
developed a correction factor for Pearson's correlation which is applicable when X and Y are
measured with error. Herein we demonstrate that correcting for measurement error by estimating
the "disattenuated" correlation substantially improves cross-platform correlations.
Conclusion: When estimating cross-platform correlation, it is essential to thoroughly evaluate
intra-platform reproducibility as a first step. In addition, since measurement error is present in
microarray gene expression data, methods to correct for attenuation are useful in decreasing the
bias in cross-platform correlation estimates.

Background
Previous microarray gene expression studies have examined within-platform reproducibility among different
generations of the Affymetrix GeneChip [1,2] and among
cDNA-based array platforms [3,4]. Subsequently, several
cross-platform reproducibility studies have been reported,

many of which examined either the consistency of intensities or the consistency with which different platforms
identify genes significantly differently expressed [5-18].
Results from another large cross-platform study, the
MicroArray Quality Control (MAQC) project, led by the
US Food and Drug Administration with 51 participating
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universities and major biotechnology companies, have
also been reported [19-24]. Some of these early studies
demonstrated poor cross-platform correlations. For example, among 384 genes commonly declared present in a
cDNA-based microarray and the Affymetrix HG-U95Av2
GeneChip platform, the Spearman correlation was only
0.131. Other cross-platform studies also reported low
cross-platform correlations [5,8]. In addition, in a study
examining three microarray platforms in ten laboratories,
correlations between Affymetrix and two-channel arrays
ranged from 0.13 – 0.57 [25]. More recent research has
demonstrated that poor correlations may be observed
when at least one platform under examination suffers
from low intra-platform reproducibility or when a poor
data analytic method is applied [26].
Most of these studies estimated Pearson's correlation as a
means of assessing cross-platform reproducibility. That is,
we consider X and Y to be microarray gene expression values from two different platforms, and ρXY is estimated.
However, for microarray data, both random variables X
and Y are subject to measurement error. It is well known
that the flourescent intensities from the scanned microarray images are proxies for the true underlying gene expression values [27]. Therefore, microarray gene expression
values are measured with error. When examining crossplatform correlation, inconsistencies in measured intensities can be due to systematic platform biases as well as random intra-platform variability. Statistical methods that
account for measurement error (ME), such as regression
calibration, have been applied in a variety of scenarios to
correct for the known bias caused by ME in parameter estimation [28]. In a recent review, the authors stated that
within the next 5 years, "calibration methods will be
introduced to systematically correct ratio underestimation
by microarray technology" [29]. We have undertaken such
an effort to account for the random intra-platform variability by developing a "disattenuated" correlation estimate [30] which accounts for random intra-platform
variation in both X and Y, and demonstrate its use in
measuring cross-platform correlation.
Microarray hybridizations were performed using three different technologies, each in a different laboratory. The
Affymetrix (Affy) HG-U133A GeneChip was utilized in
the Virginia Commonwealth University's (VCU) Division
of Molecular Diagnostics Laboratory. A custom-designed
oligonucleotide microarray designed specifically to interrogate genes more commonly expressed in brain tissue
was used in VCU's School of Engineering's Center for Bioelectronics, Biosensors and Biochips (C3B). The C3B
microarray platform comprises 10,000 genes represented
by 3' fifty-mer oligonucleotides (MWG Biotech) that were
spotted in duplicate. Finally, a cDNA microarray spotted
with full and partial length PCR probes (Research Genet-
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ics/Invitrogen) was used in George Mason University's
(GMU) Center for Biomedical Genomics and Informatics.
Each laboratory designed a small experiment to assess
intra-platform quality control. Each laboratory used the
same lot of reference RNA, the Stratagene Total Human
RNA, for hybridizing a set of technical replicates for a
process variability study. These 'self-self' hybridizations
permit meaningful assessments of reproducibility since,
under ideal circumstances such as that the same experimental conditions exist among platforms and that there
are no probe-binding affinity effects, each gene across the
set of chips should exhibit linearly related gene expression
intensities across platforms. Although the RNA hybridized
was from the same lot, the study designs and protocols
differed from lab to lab. A description of of each experiment can be found in the Methods section of this paper.

Results
Within-platform comparisons
Prior to estimating cross-platform correlations, we performed a thorough examination of intra-platform reproducibility, as recommended [29]. Since the Stratagene
Total Human RNA was used as both the experimental and
reference sample, the expected log2 ratio for all genes is 1,
so that no correlation is expected when comparing two
arrays in terms of the log2 ratio. Therefore for two channel
arrays, we restricted attention to intensities from one
channel as well as to the post-normalized intensities from
that same channel. For the Affymetrix GeneChip, intensities were highly correlated across the set of three technical
replicates for all expression summary methods (Table 1
and Figure 1). The GMU arrays were strongly correlated,
though the C3B arrays were not highly correlated (Figures
2 and 3).

The weighted kappa statistics indicated that the Affymetrix
platform had the highest agreement among ranked intensities (Table 2), followed by the GMU array which also
exhibited good agreement among the technical replicates
when considering the ranked gene intensities. The
weighted kappa statistics for C3B platform suggested the
Table 1: Average correlation for the Affymetrix, C3B, and GMU
Stratagene Technical Replicates dataset for various expression
summary methods.

Platform

Expression Summary Method

Affymetrix
(N = 22,283)

MAS 5.0
RMA
GC-RMA
Channel 1 foreground
Print-tip loess normalized Ch1
Cy5 foreground
Print-tip loess normalized Cy5

C3B
(N = 21,168)
GMU
(N = 21,168)

Average Correlation
0.9955
0.9994
0.9998
0.6560
0.6593
0.6236
0.8475
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Figure
1
Affymetrix. Pairwise scatterplots and Pearson's correlation for Affymetrix GeneChips (MAS5 summaries) restricted to the
1,288 genes in common among the three platforms.

ranked intensities from the three technical replicates were
not in agreement, yielding an insignificant p-value for two
of the array comparisons. A similar conclusion, that the
Affymetrix platform followed by the GMU array demonstrated the highest reproducibility, with low reproducibility among the C3B arrays, was noted upon examination of
the proportion of invariant features (Table 3). Although
intra-platform reproducibility varied among the three
platforms studied, all platforms yield gene expression

intensities that are subject to some degree of measurement
error.
Cross-platform comparisons
For the GMU array the 21,168 spots correspond to 19,894
distinct clones, with the feature name of each spot
denoted by Unigene ID. There were 2,744 Affy probe sets
that matched a GMU Unigene ID. Among these, 145 Unigene IDs were interrogated by more than one probe set.
After restricting attention to unique clones and probes sets
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2
C3B. Pairwise scatterplots and Pearson's correlationfor C3B arrays restricted to the 1,288 genes in common among the three
platforms.

there were 2,587 unique probe sets/clones in common to
GMU and the Affy platforms. For the C3B arrays, since its
design is essentially two identical subarrays laid out in
duplicate with the feature name of each spot denoted by
RefSeqID, the average expression for each RefSeqID was
calculated prior to merging the spots with the Affymetrix
probe sets. That is, the 21,168 long oligos correspond to
10,040 distinct genes. For the C3B array, there were 9,000
distinct RefSeqIDs were interrogated by at least one
Affymetrix probe set meeting our criteria. Once the data

from the two different 2-channel arrays were merged to
the Affymetrix GeneChip data (i.e., GMU-Affy and C3BAffy), these two resulting datasets were then merged by
Affymetrix probe set ID, resulting in 1,288 common
probe sets/spots among the three platforms.
Not accounting for measurement error, the average Pearson correlations ( ρ w) of the log transformed Affymetrix
GeneChip expression and C3B array expression are
reported in Table 4 for MAS 5.0, RMA, and GC-RMA
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Figure
GMU. Pairwise scatterplots and Pearson's correlation for GMU arrays restricted to the 1,288 genes in common among the
three platforms.

expression summaries as 'naïve' estimates of correlation.
In addition, the disattenuated correlations ( ρ ), obtained
when considering that the C3B and Affy gene intensities
are subject to measurement error, are also reported. Noting that the attenuation for the C3B arrays is 0.386, that is,
over half of the variability is attributed to measurement
error, the disattentuated correlations estimated using
measurement error models are substantially higher, irre-

spective of the Affymetrix expression summary method
used. This suggests that previous use of Pearson's correlation under-estimated true underlying cross-platform correlations. That is, the effect of the presence of random
intra-platform variation is degraded performance on the
apparent cross-platform correlation. Therefore, by removing random intra-platform variation through measurement error methodology, the cross-platform correlation
will go up.
Page 5 of 13
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Table 2: Observed agreement and p-value for each pairwise
comparison within each platform using the weighted kappa
statistic. Print-tip loess normalized Cy5 intensities were used for
both two-channel arrays; MAS5.0 expression summaries were
used for Affymetrix GeneChips.

Chips compared

Observed Agreement

disattenuated cross-platform correlations ( ρ ) for Stratagene
Technical Replicate Dataset using MAS 5.0, RMA, and GC-RMA
Affy expression summaries.

P-value

MAS 5.0
Platform

GMU
1420 v 1421
1420 v 1422
1421 v 1422
C3B
7–7 v 8–22
7–7 v 8–31
8–22 v 8–31
Affymetrix
QAQC8 v QAQC10
QAQC8 v QAQC13
QAQC10 v QAQC13

71.89%
66.31%
75.41%

< 0.0001
< 0.0001
< 0.0001

28.18%
51.82%
29.14%

1.00
< 0.0001
1.00

89.75%
89.54%
89.57%

< 0.0001
< 0.0001
< 0.0001

The average Pearson correlations ( ρ w) of the log transformed Affymetrix GeneChip expression and GMU array
expression are also reported in Table 4 for MAS 5.0, RMA,
and GC-RMA expression summaries, as well as the disattenuated correlations ( ρ ). The attenuation for the GMU
arrays is 0.824, therefore the disattenuated correlations
estimated using measurement error models are larger than
their corresponding naïve estimates, though not as markedly in comparison to the C3B arrays. This is due to the
higher reliability among the GMU expression intensities.

Discussion
In this paper, both intra- and cross-platform reproducibility was examined for the Affymetrix and two dual channel
microarrays (C3B and GMU). We applied various methods for examining within-platform reproducibility
including Pearson's correlation, the weighted kappa, and
percent of invariant genes. We also examine cross-platform reproducibility using Pearson's correlation. We previously demonstrated the effectiveness of applying a
correlation correction factor via a small simulation study
and demonstrated its application in estimating gene-specific correlations. In this paper we demonstrated its use in
Table 3: Frequency and percent of invariant features from each
platform (P < 0.0001). Print-tip loess normalized Cy5 intensities
were used for both two-channel arrays; MAS5.0 expression
summaries were used for Affymetrix GeneChips.

Affymetrix
C3B
GMU

Table 4: Cross-platform average Pearson correlations ( ρ w) and

Invariant
N, (%)

Not Invariant
N, (%)

11,732 (52.65%)
594 (2.81%)
3,036 (14.34%)

10,551 (47.35%)
20,574 (97.19%)
18,132 (85.66%)

C3B
GMU

ρ

w

0.240
0.384

RMA

ρ

ρ
0.391
0.428

w

0.210
0.348

GC-RMA

ρ

ρ
0.338
0.383

w

0.168
0.399

ρ
0.270
0.440

estimating cross-platform reproducibility. We note that
correcting for measurement error by estimating the "disattenuated" correlation removes the bias or attenuation
inherent in cross-platform correlation estimates. Specifically, to the extent that random intra-platform variation is
present, the effect is degraded performance on the apparent cross-platform correlation. Therefore, by removing
random intra-platform variation through measurement
error methodology, the cross-platform correlation will go
up.
Due to the increased public availability of gene expression
microarray data through Gene Expression Omnibus [31]
and ArrayExpress [32], researchers are increasingly interested in methods that integrate the results from various
microarray studies performed on similar types of samples
[33-37]. A careful understanding of variability due to platform-specific bias and random intra-platform variability
will help investigators select methods for integrating
cross-platform results. Specifically, the amount of attenuation for a specific platform could be used as a platformspecific quality measure and incorporated into a metaanalytic framework [38]. Moreover, gene-specific attenuation factors could be used to adjust for quality in a genewise fashion in such models.
A major application of DNA microarray technology is differential gene expression profiling, or the detection of the
differences in expression levels of genes between two different types of samples. Some have argued that the consistency of the differences via fold-change or ratio is a
more relevant metric for assessing cross-platform comparability than intensities from a single channel. However,
to estimate the correlation between fold-changes from
two platforms, two different samples are needed. We
therefore plan to use data from the MAQC project to
examine cross-platform fold-change correlations. In addition, it has been suggested that a more relevant metric is
not agreement in the identification of individual differentially expressed genes, but rather whether consistent and
accurate predictions of sample class is obtained from the
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GMU and Affy hybridizations were performed by Ph.D.
faculty members ( ρ = 0.848 and ρ = 0.996, respectively). Future studies that control for external factors that
may influence intra-platform reliability are warranted.
In calculating cross-platform correlation, we assumed that
the correlation estimated using the using the 1288 matching probes across the three platforms are representative of
expected correlation of genes in the human genome that
could be represented on the plaforms. Examination of

4000

6000

8000

10000

When estimating cross-platform correlation, it is essential
to thoroughly evaluate intra-platform reproducibility as a
first step. We also note that the commonly invoked procedure of estimating cross-platform consistency using only
probes in common to all platforms is demonstrated to
suffer from bias related to genomic coverage and probe
annotation. Future studies comparing commercially available and custom designed arrays need to take this into
consideration. Moreover, to the extent that random intraplatform variation is present, the effect is degraded performace on the apparent cross-platform correlation. Therefore, by removing random intra-platform variation
through measurement error methodology, the cross-platform correlation will go up. Methods to correct for atten-

2000

One limitation of this study is that platform is completely
confounded with laboratory technician and protocol, that
is, the platform-specific sequence of reactions, scanner,
procedures and events involved in the production of
microarray data. It was previously noted that there is a
high positive correlation between technician experience
and intra-platform correlation [25]. This is consistent
with our findings, whereby a first year graduate student
performed the C3B hybridizations ( ρ = 0.656), while the

Conclusion

0

Previous researchers demonstrated that single and two
channel microarrays yield consistent results, and concluded that the selection of which technology to use is not
necessarily a critical factor in the design of a microarray
study [20]. Here we demonstrate the critical need to thoroughly evaluate intra-platform reproducibility, a finding
which has been been noted by others [26]. In this study,
we examined two dual channel platforms and the Affymetrix platform. While the C3B and GMU platforms are not
widely used by the microarray research community, they
do represent a class of microarrays that are commonly
used, two channel custom spotted/home brewed arrays.
Thus, we believe these results are of general interest to
those who use both commercial and custom designed
arrays. While the C3B two channel platform had poor
reproducibility, the GMU two channel and Affymetrix
platforms had good reproducibility. We repeated the
intra-platform analysis using the following three sets of
randomly selected Affymetrix GeneChips (6, 12, 2), (5,
16, 14), and (5, 2, 3) and the intra-platform Affymetrix
results were consistently reproducible with what is presented in this paper. This high reproducibility of the
Affymetrix GeneChip data has also been reported by other
investigators [14,40]. These data have proven useful in
selecting a platform for studying biological specimens
being collected by our tissue bank. We recommend that
prior to performing expensive microarray hybridizations
using irreplacable biological specimens procured from
clinical studies, a thorough assessment of intra-platform
reproducibility be conducted.

absolute tag counts for the Stratagene Total Human RNA
obtained using Serial Analysis of Gene Expression data
(available from GEO #GSM1734) revealed that the intensity distribution of the 1,288 genes in common among the
three platforms is not representative of the range of
expected values (Figures 4, 5, 6, 7). Thus the commonly
invoked procedure of estimating cross-platform consistency using only probes in common to all platforms is
demonstrated to suffer from bias related to genomic coverage and probe annotation. Future studies comparing
commercially available and custom designed arrays need
to take this into consideration.

Frequency

platforms being compared [39]. This metric should be
included is such cross-platform studies as well.
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Figure
Histogram
4 of log2 absolute tag counts from SAGE
Histogram of log2 absolute tag counts from SAGE.
Histogram of log2 absolute tag counts from Serial Analysis of
Gene Expression using the Stratagene Total Human RNA for
the 14000 unique tags. Data available from GEO Accession
#GSM1734.
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Histogram
5 of log2 average Affymetrix MAS5 signal
Histogram of log2 average Affymetrix MAS5 signal.
Histogram of log2 average Affymetrix MAS5 signal for the
Stratagene Total Human RNA using the 1,288 genes in common among the three platforms.

Figure
7 of log2 average GMU signal
Histogram
Histogram of log2 average GMU signal. Histogram of
log2 average GMU signal for the Stratagene Total Human
RNA using the 1,288 genes in common among the three platforms.

uation, such as that presented, are thus useful in
decreasing such a bias in cross-platform correlation estimates. Platform-specific attenuation estimates may subse-

quently be used as a platform-specific quality measure
and incorporated into a meta-analytic framework.

Methods

600
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Stratagene Technical Replicates Dataset
Previously, each laboratory designed a small experiment
to assess intra-platform quality control. Each laboratory
used the same lot of reference RNA, the Stratagene Total
Human RNA, for hybridizing a set of technical replicates
for a process variability study. These 'self-self' hybridizations permit meaningful assessments of reproducibility
since, under ideal circumstances such as that the same
experimental conditions exist among platforms and that
there are no probe-binding affinity effects, each gene
across the set of chips should exhibit linearly related gene
expression intensities across platforms. Although the RNA
hybridized was from the same lot, the study designs and
protocols differed from lab to lab.

9
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log2μC3B

Figure
Histogram
6 of log2 average C3B signal
Histogram of log2 average C3B signal. Histogram of log2
average C3B signal for the Stratagene Total Human RNA
using the 1,288 genes in common among the three platforms.

The Affy platform was assessed using an unbalanced
three-factor design using 16 technical replicates [41]. The
same reference RNA sample was examined in 16 different
chips run on two days in four different modules of the
Affymetrix fluidics workstation. Fresh fragmented cRNAs
were hybridized to the first four GeneChips on Day 1
while frozen fragmented cRNAs were hybridized to
remaining four GeneChips on Day 1 and to all eight
GeneChips processed on Day 2. To eliminate operator
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variations, the same person completed the synthesis and
hybridization of all 16 chips. The images were scanned at
a 6 μm resolution using the Agilent G2500A Technologies
Gene Array scanner. The full set of 16 Affymetrix GeneChips is publicly available [42].
At GMU, the RNA was amplified using the MessageAmp
aRNA Kit (Ambion). The amplified RNA (aRNA) was
quantified and its quality was monitored by agarose gel
and average size by the Agilent 2100 Bioanalyzer. The
same amount of aRNA (4 μg) were labeled with Cy3 and
Cy5 according the The Institute for Genomic Research
protocol and hybridized to three Human I chips. For each
chip, the Stratagene Total Human RNA served as both the
experimental and reference sample [43]. The ScanArray
Express HT confocal laser scanner with settings at 75% of
photomultiplier tube, 75% of laser power, and 10 μm of
pixel resolution was used. Images were aquired by ScanArray Express 2.0 software and processed with QuantArray
software.
The C3B laboratory assessed quality of their fabricated
microarray using a fractional factorial design. The factors
investigated were cDNA labeling strategy (3 levels: Dye
conjugated nucleotide, aminoallyl, and Genesphere
dendimer labeling), input total RNA concentration ratio
(3 levels: 1:1, 1:2, 1:4), hybridization time (2 levels: 4 and
16 hours), hybridization buffer (3 levels: Genesphere,
MWG, and Amersham buffer), and production lot (2 levels: lot 7 and 9). Due to the expense of microarray production and hybridization, a fractional factorial design, rather
than the full factorial design, was used. Therefore, all combinations of experimental conditions were not included.
Specifically, by assuming that high-order interactions are
negligible, information regarding the main effects and
low-order interactions may be obtained by running only
a fraction of the complete factorial design. Since we were
interested in examining the effects of hybridization buffer
(3 levels), RNA input ratio (3 levels), labeling strategy (3
levels), hybridization time (2 levels), and lot (2 levels), we
were initially interested in a 33 × 22 design. However, due
to the expense involved in running a full factorial microarray experiment, a 28-2 fractional factorial design was
adopted with defining relation is I = ABCDG = ABEFH =
CDEFGH. This resolution V design permits estimation of
all main effects and two-factor interactions under the
assumption that three-way and higher order interaction
terms may be ignored. Thus our experiment required 64
C3B arrays to be hybridized given the factors and levels of
interest. Again, for each array the Stratagene Total Human
RNA served as both the experimental and reference sample. Hybridized arrays were scanned with ScanArray
Express microarray scanner (Perkin Elmer) at 80% laser
power, 70% PMT gain, and 5 μm scan resolution. Spot

http://www.biomedcentral.com/1471-2105/8/447

intensities were acquired from the images using QuantArray software.
The analyses conducted in the current study were
restricted to an equal number of chips by platform to
ensure one technology did not dominate the results simply because of having a larger sample size. Three arrays
were hybridized at GMU, so a random sample of size 3
was taken from the 16 Affy hybridized samples. These
three GeneChips were QAQC8.CEL (Day 1 Frozen),
QAQC10.CEL (Day 2 Frozen), and QAQC13.CEL (Day 2
Frozen). The three replicates selected from the C3B fractional factorial study were chosen based on 'optimal'
hybridization conditions identified from the fractional
factorial experiment. Specifically, the number of genes
found to be signficantly different from the analysis of variance model was used as the metric estimating the relative
influence of each main and two-factor interaction term.
The level of each factor having the smallest number of
genes differentially expressed was considered optimal.
The three C3B chips used in this study were hybridized
using the same buffer (Amersham), ratio of input experimental and control samples (1:1), and labeling method
(Aminoallyl Post RT). The chips differed with respect to
lot number and hybridization time, though these factors
were found to not significantly influence the resulting
intensities in the larger study.
Normalization
Since single-channel arrays measure expression intensities
on an absolute scale whereas two-channel arrays measure
expression intensities on a ratio-metric scale, we first
investigated intra-platform reproducibility using different
methods for calculating gene expression to aid in our
determination of how to best transform the intensities
from the three platforms to a similar scale. In addition,
since the objective included an assessment of platformspecific reproducibility across the set of available technical replicates, methods for within-array normalization
rather than methods that simultaneously normalize the
data across all arrays, were applied in a platform-specific
fashion.

For the two-channel arrays, we employed a commonly
used procedure of normalizing the spot-level intensities
on the array using print-tip loess regression and the subsequently analyzing the normalized spot-level intensities
[44]. The use of normalized spot intensities has removed
the systematic sources of variability (or at least, reduced)
attributed to technical artifacts of no interest, such as deposition differences, differences in labeling efficiencies,
print-tip differences etc. Specifically, due to spot differences attributed to deposition gain, print-tip, and dye
effects noted among two-channel arrays, each two-chanPage 9 of 13
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nel array (C3B and GMU) was normalized by estimating
the corrections M̂i for spots i = 1, ..., G by fitting print-tip
loess regression models to the Mi = log2(channel 1i/channel 2i) (log difference) on Ai = (log2(channel 1i) +
log2(channel 2i))/2 (log average) [45]. Probe intensities

ˆ , therefore, M norm
were then adjusted by Minorm = Mi − M
i
i
represents the normalized log ratios [46]. In addition, to
enforce an absolute expression measure, the normalized
ratios were subsequently transformed to yield the channel
1 normalized intensities by

x inorm

=2

Ai +

Minorm
2

[44]. Back-

ground was estimated by the Quantarray software as the
mean intensity among those pixels within the masked
area between the 5th and 20th percentile of intensities for a
given spot. Since simple background subtraction has been
demonstrated to increase spot-level variability [47], no
background correction was applied.
The Affymetrix GeneChip Operating System (GCOS) was
used to calculate expression summaries with a target
intensity of 100 using the Microarray Suite version 5.0
(MAS 5.0) method [48]. For completeness, we also estimated expression using the robust multiarray average
(RMA) [49] and GC-RMA methods [50], although these
methods normalize and estimate probe set expression
summaries utilizing data across the entire set of GeneChips and therefore may overestimate reproducibility. All
normalization and expression summary methods were
performed using the R software [51] and relevant Bioconductor packages [52].
Identifying common genes across platforms
The RESOURCERER annotation and cross-reference database [53] was developed to help investigators identify
genes commonly interrogated by different microarray
platforms. Other software tools such as MergeMaid [54],
GeneHopper [55], MatchMiner [56], and ProbeMatchDB
[57] have been developed for a similar purpose. Recent
research has demonstrated improved cross-platform correlations when spots are matched by sequence rather than
by gene identifiers [58-60].

Therefore, probe sets and spots with common sequences
to all three platforms were retained for analysis using the
following method. First, the GCG program 'netfetch' was
used to obtain the NCBI GenBank records for spot IDs on
the GMU and C3B microarray platforms. The perfect
match (PM) probe level sequence data for the Affymetrix
HG-U133A GeneChip was downloaded from the Affymetrix website (06/14/2005). BLASTN (v2.2.10) was used to
query the Affymetrix probe sequences against the C3B

sequences. Thereafter, all probe sets for which at least 60%
of the probes reported low e-scores values (E <0.000001)
for the same spot were retained as matches. This threshold
was determined considering the breakdown bound of the
Tukey biweight estimator used in the MAS 5.0 expression
summary algorithm. M-estimators with symmetric ψfunction have breakdown bound close to 50%. Therefore,
probe sets for which > 60% of its PM probes specifically
interrogated the same RefSeqID were retained. For the
C3B microarray, each RefSeqID is spotted two times on
the array. For the intra-platform reliability study (Stratagene dataset), average spot intensity per RefSeqID was
retained as C3B gene expression. For the Affymetrix GeneChips, when multiple probe sets interrogated the same
transcript, first, that probe set with the maximum proportion of probes with E <0.000001 was retained; when two
or more probe sets had the same proportion, then the
most 3' probe set was retained, defined by the probe set
with maximum stop query sequence location among
probes within a GenBank ID; when both quantities were
the same, the probe set was randomly selected.
This process was completed separately for the Affy-C3B
and Affy-GMU platform pairs. These two resulting datasets were merged by Affymetrix probe set ID, resulting in
a dataset containing only genes in common to all three
platforms.
All raw microarray files used in this study are publicly
available [61].
Intra-platform analyses
It has been suggested that poor cross-platform correlation
is likely a result of low intra-platform consistency [26].
Therefore, prior to estimating cross-platform reproducibility and gene-specific reliability, intra-platform reproducibility for three different microarray platforms was
examined. After normalization and calculation of gene
expression summaries, within-platform correlation was
estimated using average Pearson correlation for the K = 3
chips. In addition, reproducibility was examined by comparing the proportion of invariant genes across the set of
technical replicates within a platform. Specifically, for
spot i = 1, . . ., G, the ranked expression for the kth replicate
of platform l is denoted by Rikl. We then identified the
rank difference for each spot i within platform l as Δil =
abs(argmaxil(Rikl) - argminil(Rikl)). A gene was designated as
'invariant' for platform l using the indicator I(Δil/G ≤
0.05). As an example, this would correspond to permitting the rank to shift by no more than 1,114 when 22,283
genes are spotted on the array. Statistical tests of hypothesis comparing the proportions of invariant genes across
platforms were conducted using a chi-square test.
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Finally, the weighted kappa statistic was estimated by first
grouping gene expression intensities into 25 approximately equal-sized classes based on their ranked intensities, yi. A weighted kappa statistic was used to allow a
smaller penalty of misclassification among closely related
classes, where the weights were taken to be wrc = (1 - 0.1 ×
|r - c|) when |r - c| < 10 and 0 otherwise.
Attenuation
When fitting a linear regression model

yi = β0 + β1xi + εi

Estimating cross-platform correlation
From the intra-platform results, it is clear that microarray
gene expression data is subject to measurement error.
When estimating cross-platform correlation, let X and Y
represent the random variables for two different plat-

forms, known to be measured with error. That is, X i w = Xi
+ ui where Xi ~ N (μx, σ x2 ) and ui ~ (0, σ u2 ) while Yi w = Yi
+ vi where Yi ~ N (μy, σ y2 ), vi ~ (0, σ v2 ). The average Pearson's correlation ( ρ w), which is not corrected for measurement error, can be estimated as

for observed random variables xi and yi on observations i
3

= 1, ..., n, it is assumed xi ~ N(μx, σ x2 ), εi ~ N(0, σ e2 ) which

ρw =

is independent of xi, and xi is measured without error [62].
Using the formulas for estimating Pearson's correlation
and the slope parameter β1, Pearson's correlation can be
shown to be

∑ ρˆ(x

w , y j w )/ 3,

j =1

where x w is the average log2 Affymetrix intensities and

y j w is C3B or GMU expression. However, a more appro-

ρˆ (x, y) =

priate measure, the "disattenuated" correlation [30], can
be calculated as

σˆ x ˆ
β .
σˆ y 1

Therefore, Pearson's correlation measures the strength of
the linear relationship between X and Y.

ρw = λp × ρ
where

For a general problem, suppose xi cannot be measured
precisely but rather is measured with error. Denote the
error-prone measurements x i w = xi + ui where ui ~ (0, σ u2 ).
It is well known that fitting the model

λp =

σ xσ y
.
2
σ x +σ u2 σ y2 +σ v2

y i = β 0 + β 1∗ x i w + ε i

This estimate adjusts for the bias present in estimating the
correlation when measurement error is present. Estimates
for σx, σu, σy, and σv were fit using the regression calibra-

using the error-prone values x i w leads to the attenuated

tion rcal function in Stata version 9 [63]. In estimating σ u2

estimate β1* for β1 [28]. That is, the slope parameter is

and σ v2 , the repeated measurements were assumed to be

biased. Therefore, when fitting a simple linear regression
model using the error prone measurements x i w , the least-

unbiased for the true gene expression values. Moreover,
any missing value was treated as missing at random. Previous investigators have reported high reproducibility
estimates for Affymetrix expression values [14,40], therefore, we were primarily interested in estimating the correlation between Affymetrix and the custom designed arrays
(C3B and GMU) that we have used in various cancer
genomics projects. The disattenuated correlation, ρ , and

squares estimate is

β1* = λβ1,
where β1 is the true slope parameter describing the relationship between yi and xi and λ is the attenuation factor.
The attenuation factor is given by

λ=

σ x2

/(σ x2

+ σ u2 )

<1

and is used to estimate β1 when measurement error is
present in both X and Y [28].

average Pearson correlation, ρ w, were estimated separately for the GMU and C3B platforms relative to Affymetrix.
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